Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the pharmacokinetics of NKTR-118 in patients with impaired hepatic function versus subjects with normal hepatic function.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01392807
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 1
Start date July 2011
Completion date November 2011